Sandoz
FDA Approves Pyzchiva Biosimilar to Stelara
Pyzchiva was approved for all indications of its reference biologic; the FDA provisionally determined that ...
JULY 3, 2024
Sandoz, Novartis Recall Prescription Drug Blister Packs That Fail Child Safety Closures
The pharmaceutical companies Sandoz and Novartis issued a voluntary recall of prescription drug blister packages ...
JULY 9, 2018
Sandoz Launches Generic Emend Capsules
The generic aprepitant will have the same indications as the branded Emend: nausea and vomiting from chemotherapy ...
JANUARY 11, 2017
FDA Approves Erelzi, a Biosimilar to Enbrel
Administered by injection, Erelzi received approval for all the indications of the reference product.
AUGUST 31, 2016
Crestor Available in Generic Form
U.S. sales of Crestor were approximately $6.7 billion for the 12 months ending May 2016.
JULY 21, 2016
FDA’s Woodcock Fears Biosimilars Explosion
A persistent funding gap is hampering the FDA's ability to review the surge of biosimilars applications, Janet ...
FEBRUARY 5, 2016
